The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Following the cardiovascular safety review of all NSAIDs and concerns regarding the risk of hepatotoxicity, the Office of Product Review (OPR) conducted a full safety review of diclofenac.